Divi’s Labs to release Q1FY26 results on August 6, earnings call at 1:30 PM IST
NOOR MOHMMED
28/Jul/2025

-
Divi’s Labs will declare Q1FY26 unaudited financial results on August 6, 2025, and host an earnings call the same day at 1:30 PM IST.
-
Dial-in and DiamondPass links are provided for analysts and investors to participate in the earnings conference call.
-
Transcript of the earnings call will be available on the company’s official website, www.divislabs.com.
Divi’s Laboratories to announce Q1FY26 financials on August 6; earnings call scheduled at 1:30 PM IST
Hyderabad, July 28, 2025 – Divi’s Laboratories Limited, a leading Indian pharmaceutical company, has announced that it will declare its unaudited financial results for the first quarter of FY26 (April–June 2025) on Tuesday, August 6, 2025. The results will be followed by an earnings conference call at 1:30 PM IST to discuss the company’s performance for the quarter ended June 30, 2025.
The company has submitted an official intimation to the BSE (Scrip Code: 532488) and the NSE (Trading Symbol: DIVISLAB) in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.
As per the announcement, investors and analysts can join the earnings call using the following methods:
Option 1: DiamondPass™ (Pre-registered Access)
Participants can pre-register via the DiamondPass™ link to skip operator queues and directly join the conference:
Option 2: Dial-in Access
Investors who prefer standard dial-in can use these numbers:
📞 Universal Dial-in Numbers:
-
+91 22 6280 1526
-
+91 22 7115 8341
Participants are advised to dial in five minutes before the scheduled start to avoid delays. The operator will explain how participants can ask questions during the call.
The company has confirmed that a complete transcript of the call will be uploaded on its website, www.divislabs.com, shortly after the event.
For investor-related queries or assistance, stakeholders can reach out via:
-
📱 Mobile: +91 91542 18881
-
☎️ Phone: +91 40 66966352
This earnings call will give stakeholders a detailed view of Divi’s Labs’ quarterly performance, insights into business strategy, cost structures, and outlook for the remainder of the fiscal year.
Divi’s Laboratories is known for its leadership in active pharmaceutical ingredients (APIs) and has a strong track record of delivering consistent financial performance and maintaining regulatory compliance across global markets.
The Upcoming IPOs in this week and coming weeks are M&B Engineering, Cash Ur Drive Marketing, Renol Polychem, Jyoti Global Plast, Takyon Networks, Mehul Colours, Aditya Infotech, Sri Lotus Developers & Realty, Lakshmi India Finance, Jyoti Global Plast, B.D. Industries (Pune), Kaytex Fabrics, Umiya Mobile, Repono, NSDL.
The Current active IPO are Shree Refrigerations, Sellowrap Industries, Shanti Gold International, Patel Chem Specialities, Brigade Hotel Ventures, Indiqube Spaces, GNG Electronics, TSC India.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.